|
|
|
Volumn 42, Issue 3, 1990, Pages 223-286
|
|
Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideratiion of promising developmental stage compounds
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID RECEPTOR;
ACETAZOLAMIDE;
AMINO ACID RECEPTOR;
ANTICONVULSIVE AGENT;
BARBITURIC ACID DERIVATIVE;
BENZODIAZEPINE DERIVATIVE;
BENZODIAZEPINE RECEPTOR;
CALCIUM CHANNEL;
CARBAMAZEPINE;
DENZIMOL;
ETHOSUXIMIDE;
FLUNARIZINE;
HYDANTOIN DERIVATIVE;
LAMOTRIGINE;
MESUXIMIDE;
NAFIMIDONE;
OXCARBAZEPINE;
PHENACEMIDE;
PHENSUXIMIDE;
PHENYTOIN;
PROGABIDE;
RALITOLINE;
REMACEMIDE;
SODIUM CHANNEL;
STIRIPENTOL;
TOPIRAMATE;
TRIMETHADIONE;
VALPROIC ACID;
VIGABATRIN;
ZONISAMIDE;
EPILEPSY;
FOCAL EPILEPSY;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TONIC CLONIC SEIZURE;
ANIMAL;
ANTICONVULSANTS;
DRUG DESIGN;
HUMAN;
SEIZURES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0025050694
PISSN: 00316997
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (659)
|
|
References (0)
|
